Aikaterini Anagnostou, MD, PhD, is professor of pediatrics at Baylor College of Medicine and Texas Children’s Hospital. She serves as director of the Food Immunotherapy Program, director of the Food Challenge Program, and co-director of the Food Allergy Program. She is also lead for Adolescent Transition for Allergy. 

Dr Anagnostou is passionate about investigating new and innovative treatments for food allergy. She has developed a strong interest in preventing and treating all forms of allergic disease and is committed to improving the quality of life of patients with allergies and their families.

Dr Anagnostou studied medicine at Aristotle University of Thessaloniki and graduated with first-class honors in 2000. She obtained her PhD from the University of Cambridge in the United Kingdom. Her dissertation focused on 2 separate trials of peanut oral immunotherapy in children. Her research was published in The Lancet and received international recognition. 

David M. Fleischer, MD, is currently the section head of allergy and immunology at Children’s Hospital Colorado (CHCO) and a professor of pediatrics at CHCO and the University of Colorado Denver School of Medicine. He is also the director of the Allergy and Immunology Center at CHCO, which opened in February 2018. Dr Fleischer completed his undergraduate training at the University of Pennsylvania, his medical degree training at the Emory University School of Medicine, and both his pediatric residency and his pediatric allergy/immunology fellowship training at the Johns Hopkins University School of Medicine. 

Dr Fleischer’s primary clinical interest is food allergy. His research has focused on the natural history of and novel treatments for food allergy, including oral, sublingual, and epicutaneous immunotherapies. He has authored numerous original peer-reviewed articles, review articles, and book chapters on food allergy.